By contrast, PQLC3 and ALG14 are primarily supported by bioinformatic associations or non-oncologic literature: PQLC3 has been identified in prognostic and tumor mutational burden-related gene sets, whereas ALG14 is a canonical component of N-linked glycosylation (53–55). This evidence concerns the gene ALG14 and neoplasm.